← Leaderboards
Brendan D. Manning
Harvard School Of Public Health
$14,486,143
Attributed
$14,486,143
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,486,143 · 5
By mechanism
R35$9,825,427 · 1
R01$3,087,097 · 2
P01$1,134,994 · 1
R21$438,625 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexPathway InteractionsSignal TransductionMolecularMalignant NeoplasmsRegulationCellsTumor Suppressor GenesSignal PathwayOncogenicGrowthNormal CellTumor Suppressor ProteinsTuberous Sclerosis Protein ComplexTumorNeoplastic CellGeneticFamilyMetabolicGrowth FactorGrantCell GrowthMemberMonomeric Gtp-Binding Proteins
Grant awards (29)
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer$959,712
R35 · FY2025 · CA · contact PI
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer$911,728
R35 · FY2024 · CA · contact PI
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer$932,003
R35 · FY2023 · CA · contact PI
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer$974,587
R35 · FY2022 · CA · contact PI
Neurodevelopmental Function of TBC1D7: A Core Component of the TSC Complex$438,625
R21 · FY2022 · NS · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$834,405
R35 · FY2021 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$904,904
R35 · FY2020 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$877,757
R35 · FY2019 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$924,904
R35 · FY2018 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$924,904
R35 · FY2017 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$924,904
R35 · FY2016 · CA · contact PI
Molecular wiring and therapeutic targeting of the TSC-Rheb signaling network$229,556
P01 · FY2016 · CA · contact PI
Decoding and targeting the PI3K-mTOR signaling network in cancer$655,619
R35 · FY2015 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$383,563
R01 · FY2015 · CA · contact PI
Molecular wiring and therapeutic targeting of the TSC-Rheb signaling network$229,954
P01 · FY2015 · CA · contact PI
Metabolic control of cell growth by the mTOR signaling network$28,142
R01 · FY2015 · CA · contact PI
Metabolic control of cell growth by the mTOR signaling network$353,081
R01 · FY2014 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$250,558
R01 · FY2014 · CA · contact PI
Molecular wiring and therapeutic targeting of the TSC-Rheb signaling network$222,404
P01 · FY2014 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$242,810
R01 · FY2013 · CA · contact PI
Molecular wiring and therapeutic targeting of the TSC-Rheb signaling network$215,276
P01 · FY2013 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$258,308
R01 · FY2012 · CA · contact PI
Molecular wiring and therapeutic targeting of the TSC-Rheb signaling network$237,804
P01 · FY2012 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$258,308
R01 · FY2011 · CA · contact PI
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors$266,297
R01 · FY2010 · CA · contact PI
Pathologic and therapeutic implications of Akt attenuation in TSC cells and tumor$255,599
R01 · FY2009 · CA · contact PI
Pathologic and therapeutic implications of Akt attenuation in TSC cells and tumor$255,599
R01 · FY2008 · CA · contact PI
Pathologic and therapeutic implications of Akt attenuation in TSC cells and tumor$255,599
R01 · FY2007 · CA · contact PI
Pathologic and therapeutic implications of Akt attenuation in TSC cells and tumor$279,233
R01 · FY2006 · CA · contact PI